These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11173169)

  • 1. Effects of urine testing frequency on outcome in a methadone take-home contingency program.
    Chutuape MA; Silverman K; Stitzer ML
    Drug Alcohol Depend; 2001 Mar; 62(1):69-76. PubMed ID: 11173169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of methadone take-home contingencies with persistent opiate and cocaine abusers.
    Chutuape MA; Silverman K; Stitzer ML
    J Subst Abuse Treat; 1999 Jan; 16(1):23-30. PubMed ID: 9888118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contingent take-home incentive: effects on drug use of methadone maintenance patients.
    Stitzer ML; Iguchi MY; Felch LJ
    J Consult Clin Psychol; 1992 Dec; 60(6):927-34. PubMed ID: 1460154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The brief abstinence test: voucher-based reinforcement of cocaine abstinence.
    Robles E; Silverman K; Preston KL; Cone EJ; Katz E; Bigelow GE; Stitzer ML
    Drug Alcohol Depend; 2000 Feb; 58(1-2):205-12. PubMed ID: 10669073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voucher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadone patients: effects of reinforcer magnitude.
    Dallery J; Silverman K; Chutuape MA; Bigelow GE; Stitzer ML
    Exp Clin Psychopharmacol; 2001 Aug; 9(3):317-25. PubMed ID: 11534542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study.
    Gonzalez G; Sevarino K; Sofuoglu M; Poling J; Oliveto A; Gonsai K; George TP; Kosten TR
    Addiction; 2003 Nov; 98(11):1625-32. PubMed ID: 14616189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency.
    Epstein DH; Schmittner J; Umbricht A; Schroeder JR; Moolchan ET; Preston KL
    Drug Alcohol Depend; 2009 Apr; 101(1-2):92-100. PubMed ID: 19101098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad beneficial effects of cocaine abstinence reinforcement among methadone patients.
    Silverman K; Wong CJ; Umbricht-Schneiter A; Montoya ID; Schuster CR; Preston KL
    J Consult Clin Psychol; 1998 Oct; 66(5):811-24. PubMed ID: 9803700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do noncontingent vouchers increase drug use?
    Schroeder JR; Gupman AE; Epstein DH; Umbricht A; Preston KL
    Exp Clin Psychopharmacol; 2003 Aug; 11(3):195-201. PubMed ID: 12940498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contingency management for cocaine use in methadone maintenance patients: when does abstinence happen?
    Weinstock J; Rash CJ; Petry NM
    Psychol Addict Behav; 2010 Jun; 24(2):282-91. PubMed ID: 20565154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.
    Schottenfeld RS; Chawarski MC; Pakes JR; Pantalon MV; Carroll KM; Kosten TR
    Am J Psychiatry; 2005 Feb; 162(2):340-9. PubMed ID: 15677600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing.
    Huestis MA; Cone EJ; Wong CJ; Umbricht A; Preston KL
    J Anal Toxicol; 2000 Oct; 24(7):509-21. PubMed ID: 11043653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a baseline urine test predict levels of cocaine use during treatment.
    Ehrman RN; Robbins SJ; Cornish JW
    Drug Alcohol Depend; 2001 Mar; 62(1):1-7. PubMed ID: 11173162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abstinence-contingent reinforcement and engagement in non-drug-related activities among illicit drug abusers.
    Rogers RE; Higgins ST; Silverman K; Thomas CS; Badger GJ; Bigelow G; Stitzer M
    Psychol Addict Behav; 2008 Dec; 22(4):544-50. PubMed ID: 19071979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contingent reinforcement sustains post-detoxification abstinence from multiple drugs: a preliminary study with methadone patients.
    Chutuape MA; Silverman K; Stitzer M
    Drug Alcohol Depend; 1999 Mar; 54(1):69-81. PubMed ID: 10101619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance.
    Preston KL; Umbricht A; Epstein DH
    Arch Gen Psychiatry; 2000 Apr; 57(4):395-404. PubMed ID: 10768702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contingency management in methadone maintenance: effects of reinforcing and aversive consequences on illicit polydrug use.
    Iguchi MY; Stitzer ML; Bigelow GE; Liebson IA
    Drug Alcohol Depend; 1988 Oct; 22(1-2):1-7. PubMed ID: 2906863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: a randomized controlled trial.
    Holtyn AF; Koffarnus MN; DeFulio A; Sigurdsson SO; Strain EC; Schwartz RP; Leoutsakos JM; Silverman K
    Prev Med; 2014 Nov; 68():62-70. PubMed ID: 24607365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment.
    Levine AR; Lundahl LH; Ledgerwood DM; Lisieski M; Rhodes GL; Greenwald MK
    J Subst Abuse Treat; 2015 Jul; 54():37-43. PubMed ID: 25795601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voucher-based contingent reinforcement of smoking abstinence among methadone-maintained patients: a pilot study.
    Dunn KE; Sigmon SC; Thomas CS; Heil SH; Higgins ST
    J Appl Behav Anal; 2008; 41(4):527-38. PubMed ID: 19192857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.